Modulating Fibrotic Mechanical Microenvironment for Idiopathic Pulmonary Fibrosis Therapy
Advanced Materials · 2024-12 · 36 (50)
DOI: 10.1002/adma.202407661 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 12.11.2024. Verfasst von Xue-Na Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Yanbian University, Yanji, 133002, China. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is exacerbated by injurious mechanical forces that destabilize the pulmonary mechanical microenvironment homeostasis, leading to alveolar dysfunction and exacerbating disease severity. However, given the inherent mechanosensitivity of fibrotic lungs, where type II alveolar epithelial cells (AEC IIs) are subjected to persistent stretching and overactivated myofibroblasts experience malignant interactions during mechanotransduction, it becomes imperative to develop effective strategies to modulate the pulmonary mechanical microenvironment. Herein, cyclo (RGDfC) peptide‐decorated zeolitic imidazolate framework‐8 nanoparticles (named ZDFPR NPs) are constructed to target and repair the aberrant mechanical force levels in pathological lungs. Specifically, reduces mechanical tension in AEC IIs by pH‐responsive ZDFPR NPs that release zinc ions and 7, 8‐dihydroxyflavone to promote alveolar repair and differentiation. Meanwhile, malignant interactions between myofibroblast contractility and extracellular matrix stiffness during mechanotransduction are disrupted by the fasudil inhibition ROCK signaling pathway. The results show that ZDFPR NPs successfully restored pulmonary mechanical homeostasis and terminated the fibrosis process in bleomycin‐induced fibrotic mice. This study not only presents a promising strategy for modulating pulmonary mechanical microenvironment but also pioneers a novel avenue for IPF treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Yanbian University, Yanji, 133002, China.
- State Key Laboratory of Natural Medicines, Department of Pharmaceuticals, China Pharmaceutical University, Nanjing, 210009, China.
- Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing, 210009, China.
- Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon, 16419, South Korea.
ORCID-Profile: Hu-Lin Jiang
Förderung
- National Key Research and Development Program of China
- Project of State Key Laboratory of Natural Medicines
- China Pharmaceutical University
- Natural Science Foundation of Jiangsu Basic Research Program-Project
- National Natural Science Foundation of China
Zitieren
APA
Li, X. N., Lin, Y. P., Han, M. M., Fang, Y. F., Xing, L., Jeong, J. H., & Jiang, H. L. (2024). Modulating Fibrotic Mechanical Microenvironment for Idiopathic Pulmonary Fibrosis Therapy. Advanced Materials, 36(50). https://doi.org/10.1002/adma.202407661
Vancouver
Li XN, Lin YP, Han MM, Fang YF, Xing L, Jeong JH, et al. Modulating Fibrotic Mechanical Microenvironment for Idiopathic Pulmonary Fibrosis Therapy. Advanced Materials. 2024;36(50). doi:10.1002/adma.202407661
BibTeX
@article{Li2024,
author = {Li, Xue-Na and Lin, Ya-Ping and Han, Meng-Meng and Fang, Yue-Fei and Xing, Lei and Jeong, Jee-Heon and Jiang, Hu-Lin},
title = {Modulating Fibrotic Mechanical Microenvironment for Idiopathic Pulmonary Fibrosis Therapy},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {50},
doi = {10.1002/adma.202407661}
}
EUVIMED